Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PBMs, Retail Pharmacies Vow To Cooperate On Electronic Prescribing

This article was originally published in The Pink Sheet Daily

Executive Summary

SureScripts, the retail pharmacy e-prescribing network, and RxHub, established by PBMs, are “complementary” organizations, RxHub CEO McLean tells House hearing. HHS plans to issue proposed electronic prescribing standards by year-end.

You may also be interested in...



FTC Slams Surescripts' E-Prescribing Networks, Says 'Web Of Loyalty Contracts' Blocks Competition

Surescripts maintained a monopoly on electronic prescription routing and eligibility markets through exclusive contracts with pharmacies and PBMs, complaint alleges.

Patient Safety Bill Passes Senate Without E-Prescribing Funding

Sen. Kennedy hopes to include e-prescribing grant funding during conference committee expected in September; House bill includes $25 mil. The bill allows patient safety data disclosure for use in liability lawsuits under certain circumstances.

Patient Safety Bill Passes Senate Without E-Prescribing Funding

Sen. Kennedy hopes to include e-prescribing grant funding during conference committee expected in September; House bill includes $25 mil. The bill allows patient safety data disclosure for use in liability lawsuits under certain circumstances.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS060090

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel